IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia

BACKGROUND: Heparin-induced thrombocytopenia (HIT) complicated by severe thrombocytopenia and thrombosis can pose significant treatment challenges. Use of alternative anticoagulants in this setting may increase bleeding risks, especially in patients who have a protracted disease course. Additional t...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Chest
Main Authors: Padmanabhan, Anand, Jones, Curtis G., Pechauer, Shannon M., Curtis, Brian R., Bougie, Daniel W., Irani, Mehraboon S., Bryant, Barbara J., Alperin, Jack B., Deloughery, Thomas G., Mulvey, Kevin P., Dhakal, Binod, Wen, Renren, Wang, Demin, Aster, Richard H.
Formato: Artigo
Idioma:Inglês
Publicado: American College of Chest Physicians 2017
Assuntos:
Antithrombotic Therapy
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5812774/
https://ncbi.nlm.nih.gov/pubmed/28427966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chest.2017.03.050
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares